IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 253 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,858,355 | +64531.0% | 3,705,133 | 0.0% | 0.90% | -25.9% |
| Q2 2023 | $26,084 | +15.2% | 3,705,133 | 0.0% | 1.21% | +8.8% |
| Q1 2023 | $22,638 | -99.8% | 3,705,133 | +146.2% | 1.11% | +119.3% |
| Q4 2022 | $9,617,800 | -48.1% | 1,505,133 | -22.2% | 0.51% | -51.4% |
| Q3 2022 | $18,539,000 | -13.2% | 1,935,133 | 0.0% | 1.04% | -22.9% |
| Q2 2022 | $21,364,000 | -33.7% | 1,935,133 | 0.0% | 1.35% | -18.3% |
| Q1 2022 | $32,220,000 | +53.4% | 1,935,133 | +75.9% | 1.66% | +102.9% |
| Q4 2021 | $20,999,000 | -22.6% | 1,100,000 | 0.0% | 0.82% | -13.8% |
| Q3 2021 | $27,126,000 | +394.1% | 1,100,000 | +450.0% | 0.95% | +292.9% |
| Q2 2020 | $5,490,000 | – | 200,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 12,201,261 | $203,150,000 | 4.07% |
| Paradigm Biocapital Advisors LP | 907,428 | $15,109,000 | 4.00% |
| Avoro Capital Advisors LLC | 9,125,000 | $151,931,000 | 2.77% |
| Logos Global Management LP | 1,000,000 | $16,650,000 | 2.16% |
| Avidity Partners Management LP | 6,043,219 | $100,620,000 | 2.10% |
| Orbimed Advisors | 6,633,006 | $110,440,000 | 1.79% |
| Parametrica Management Ltd | 134,679 | $2,240,000 | 1.66% |
| Boxer Capital, LLC | 1,935,133 | $32,220,000 | 1.66% |
| Fairmount Funds Management LLC | 389,588 | $6,487,000 | 1.53% |
| Long Focus Capital Management, LLC | 705,000 | $11,738,000 | 1.51% |